Kallikrein
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
- | <StructureSection load='2bdh' size='340' side='right' caption='Structure of human kallikrein 4 complex with p-aminobenzamidine and Zn+2 ion (grey) (PDB code [[2bdh]])' scene=''> | + | <StructureSection load='2bdh' size='340' side='right' caption='Structure of human kallikrein 4 complex with p-aminobenzamidine and Zn+2 ion (grey) (PDB code [[2bdh]])' scene='59/595822/Cv/1'> |
== Function == | == Function == |
Revision as of 12:03, 10 April 2016
|
3D Structures of kallikrein
Updated on 10-April-2016
References
- ↑ Bryant JW, Shariat-Madar Z. Human plasma kallikrein-kinin system: physiological and biochemical parameters. Cardiovasc Hematol Agents Med Chem. 2009 Jul;7(3):234-50. PMID:19689262
- ↑ Feener EP. Plasma kallikrein and diabetic macular edema. Curr Diab Rep. 2010 Aug;10(4):270-5. doi: 10.1007/s11892-010-0127-1. PMID:20535647 doi:http://dx.doi.org/10.1007/s11892-010-0127-1
- ↑ Pampalakis G, Sotiropoulou G. Multiple mechanisms underlie the aberrant expression of the human kallikrein 6 gene in breast cancer. Biol Chem. 2006 Jun;387(6):773-82. PMID:16800739 doi:http://dx.doi.org/10.1515/BC.2006.097
- ↑ Debela M, Magdolen V, Grimminger V, Sommerhoff C, Messerschmidt A, Huber R, Friedrich R, Bode W, Goettig P. Crystal structures of human tissue kallikrein 4: activity modulation by a specific zinc binding site. J Mol Biol. 2006 Oct 6;362(5):1094-107. Epub 2006 Aug 3. PMID:16950394 doi:10.1016/j.jmb.2006.08.003